List of Light Sciences Oncology patents | 7 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8235975 Light transmission system for photoreactive therapy	Patent 8235975 was granted and assigned to Light Sciences Oncology on August, 2012 by the United States Patent and Trademark Office.		Light Sciences Oncology	United States Patent and Trademark Office	8235975	August 7, 2012
‌ US Patent 8097028 Photoreactive system and methods for prophylactic treatment of atherosclerosis	Patent 8097028 was granted and assigned to Light Sciences Oncology on January, 2012 by the United States Patent and Trademark Office.		Light Sciences Oncology	United States Patent and Trademark Office	8097028	January 17, 2012
‌ US Patent 8226946 Enhancement of light activated therapy by immune augmentation using anti-CTLA-4 antibody	Patent 8226946 was granted and assigned to Light Sciences Oncology on July, 2012 by the United States Patent and Trademark Office.		Light Sciences Oncology	United States Patent and Trademark Office	8226946	July 24, 2012
‌ US Patent 7730894 Photodynamic therapy apparatus and method for vascular tissue treatment	Patent 7730894 was granted and assigned to Light Sciences Oncology on June, 2010 by the United States Patent and Trademark Office.		Light Sciences Oncology	United States Patent and Trademark Office	7730894	June 8, 2010
‌ US Patent RE47491 Light transmission system for photoreactive therapy	Patent RE47491 was granted and assigned to Light Sciences Oncology on July, 2019 by the United States Patent and Trademark Office.	Purdue Pharma	Light Sciences Oncology	United States Patent and Trademark Office	RE47491	July 9, 2019
‌ US Patent 7767208 Noninvasive vascular therapy	Patent 7767208 was granted and assigned to Light Sciences Oncology on August, 2010 by the United States Patent and Trademark Office.		Light Sciences Oncology	United States Patent and Trademark Office	7767208	August 3, 2010
‌ US Patent 7993640 Enhancement of light activated therapy by immune augmentation using anti-CTLA-4 antibody	Patent 7993640 was granted and assigned to Light Sciences Oncology on August, 2011 by the United States Patent and Trademark Office.		Light Sciences Oncology	United States Patent and Trademark Office	7993640	August 9, 2011